Companies › SXTC

CHINA SXT PHARMACEUTICALS IN (SXTC)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001723980 · EDGAR filings · Updated 2026-07-24

CHINA SXT PHARMACEUTICALS IN (SXTC) has reported institutional ownership of 8.2%, with 4 institutional managers holding positions valued at $131.3K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-24 — Foreign issuer report (6-K) filed
• 2026-07-24 — Prospectus supplement (424B5) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-07 — F-3 filed
• 2026-07-06 — Foreign issuer report (6-K) filed
• 2026-07-01 — Annual report (20-F) filed
• 2026-06-01 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CHINA SXT PHARMACEUTICALS IN has 4 institutional holders and institutional ownership of 8.2%.

Data flags from SEC filings

Related companies

HCW Biologics Inc (HCWB) · SONOMA PHARMACEUTICALS INC (SNOA) · VivoSim Labs Inc (VIVS) · Dermata Therapeutics Inc (DRMA) · Indaptus Therapeutics Inc (INDP) · Sunshine Biopharma Inc (SBFM)